SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Tomorrow.io raises $175 million at over $1 billion valuation to build AI-driven weather satellite network

Cyber startup Orion raises $32 million Series A backed by IBM for AI-driven data-leak prevention

Full list of Israeli startup M&As in 2026

Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion

Buzz

Most popular

Daily

Weekly

1

Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”

2

Why Apple paid billions for a company with no revenue

3

Israeli startups raise over $1 billion in January, marking best opening month since 2022

4

Valued at $800 million after less than two years, Vega eyes the path blazed by Wiz

5

“SaaS is dying as a business category”

Nestlé

3 stories about Nestlé

גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki

Investors are hopeful, but the company must now face an uphill battle in a crowded market.

גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki

The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level

A Beloved Israeli Snack Prepares to Take Bigger Bite Out of American Market

07.02.19|Navit Zomer

Generations of Israeli kids grew up eating peanut butter flavored snack Bamba. Now, manufacturer Osem is negotiating a distribution agreement that could make the snack as wildly popular with American kids